Jiansu Sihuan Overview
- Status
-
Public
- Employees
-
232
- Stock Symbol
-
000518
- Investments
-
2
- Share Price
-
$0.46
- (As of Thursday Closing)
Jiansu Sihuan General Information
Description
Jiansu Sihuan Bioengineering Co Ltd operates in the pharmaceutical industry. The products of the company include large volume injection, small volume injection, tablets, hard capsules, syrups, oral solutions, wine agent, bulk drug, Chinese medicine extraction, and manufacture of second-class psychotropic drugs.
Contact Information
Website
www.jiangsu-sihuan.en.ywsp.comCorporate Office
- No. 10 Dingshan Road
- Binjiang Development Zone
- Jiangyin, Jiangsu 214434
- China
Corporate Office
- No. 10 Dingshan Road
- Binjiang Development Zone
- Jiangyin, Jiangsu 214434
- China
Jiansu Sihuan Stock Performance
As of 12-Nov-2026, Jiansu Sihuan’s stock price is $0.46. Its current market cap is $478M with 1.03B shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.46 | $0.46 | $0.33 - $0.67 | $478M | 1.03B | 34.9M | -$0.01 |
Jiansu Sihuan Financials Summary
As of 30-Sep-2026, Jiansu Sihuan has a trailing 12-month revenue of $41.2M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 550,142 | 349,882 | 365,530 | 489,506 |
| Revenue | 41,183 | 47,889 | 28,363 | 33,275 |
| EBITDA | (11,326) | (2,947) | (12,561) | (7,627) |
| Net Income | (10,577) | (5,158) | (15,329) | (10,639) |
| Total Assets | 105,897 | 70,611 | 77,725 | 93,245 |
| Total Debt | 22,226 | 4,310 | 4,969 | 6,758 |
Jiansu Sihuan Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Jiansu Sihuan Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Jiansu Sihuan Acquisitions (2)
Jiansu Sihuan’s most recent deal was a Merger/Acquisition with Changyuan Pharmaceutical for . The deal was made on 16-Oct-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Changyuan Pharmaceutical | 16-Oct-2026 | Merger/Acquisition | Pharmaceuticals | ||
| Zorun Pharma | 10-Oct-2026 | Merger/Acquisition | Pharmaceuticals |
Jiansu Sihuan ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Jiansu Sihuan Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Zorun Pharma | Guangzhou, China | 2017 | |
| Changyuan Pharmaceutical | Changchun, China | 2001 |
Jiansu Sihuan FAQs
-
Where is Jiansu Sihuan headquartered?
Jiansu Sihuan is headquartered in Jiangyin, China.
-
What is the size of Jiansu Sihuan?
Jiansu Sihuan has 232 total employees.
-
What industry is Jiansu Sihuan in?
Jiansu Sihuan’s primary industry is Pharmaceuticals.
-
Is Jiansu Sihuan a private or public company?
Jiansu Sihuan is a Public company.
-
What is Jiansu Sihuan’s stock symbol?
The ticker symbol for Jiansu Sihuan is 000518.
-
What is the current stock price of Jiansu Sihuan?
As of 12-Nov-2026 the stock price of Jiansu Sihuan is $0.46.
-
What is the current market cap of Jiansu Sihuan?
The current market capitalization of Jiansu Sihuan is $478M.
-
What is Jiansu Sihuan’s current revenue?
The trailing twelve month revenue for Jiansu Sihuan is $41.2M.
-
What is Jiansu Sihuan’s annual earnings per share (EPS)?
Jiansu Sihuan’s EPS for 12 months was -$0.01.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
